RA Capital Management, L.P. 13D and 13G filings for NewAmsterdam Pharma Company N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 6:42 pm Purchase |
2024-12-31 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
RA Capital Management, L.P. | 10,875,454 9.900% |
1,779,865 (+19.57%) |
Filing |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
RA Capital Management, L.P. | 9,095,589 9.990% |
898,256 (+10.96%) |
Filing |
| 2024-02-14 5:01 pm Sale |
2024-02-14 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
RA Capital Management, L.P. | 8,197,333 9.900% |
-1,136,000 (-12.17%) |
Filing |
| 2023-08-01 4:30 pm Purchase |
2023-06-08 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
RA Capital Management, L.P. | 9,333,333 11.300% |
5,000,000 (+115.38%) |
Filing |
| 2022-12-02 4:30 pm Purchase |
2022-11-22 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
RA Capital Management, L.P. | 4,333,333 5.290% |
4,333,333 (New Position) |
Filing |